Bruno Catalanotti

1.9k total citations
59 papers, 1.4k citations indexed

About

Bruno Catalanotti is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Bruno Catalanotti has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Bruno Catalanotti's work include DNA and Nucleic Acid Chemistry (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and RNA Interference and Gene Delivery (8 papers). Bruno Catalanotti is often cited by papers focused on DNA and Nucleic Acid Chemistry (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and RNA Interference and Gene Delivery (8 papers). Bruno Catalanotti collaborates with scholars based in Italy, Switzerland and Sweden. Bruno Catalanotti's co-authors include Caterina Fattorusso, Giuseppe Campiani, Ettore Novellino, Vito Nacci, Stefania Butini, Sandra Gemma, Ashima Saxena, Anna Ramunno, Luisa Savini and Marco Persico and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Bruno Catalanotti

57 papers receiving 1.4k citations

Peers

Countries citing papers authored by Bruno Catalanotti

Since Specialization

Citations

This map shows the geographic impact of Bruno Catalanotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Catalanotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Catalanotti more than expected).

Fields of papers citing papers by Bruno Catalanotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Catalanotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Catalanotti. The network helps show where Bruno Catalanotti may publish in the future.

Co-authorship network of co-authors of Bruno Catalanotti

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Catalanotti. A scholar is included among the top collaborators of Bruno Catalanotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Catalanotti. Bruno Catalanotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor Modulation	ACS Omega	Claudia Finamore, Carmen Festa et al.	2
2	Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis	Journal of Medicinal Chemistry	Federica Moraca, Elva Morretta et al.	0
3	Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis	Journal of Medicinal Chemistry	Claudia Finamore, Cristina Di Giorgio et al.	6
4	Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders	ACS Omega	Rosalinda Roselli, Claudia Finamore et al.	5
5	Ubiquitylation of BBSome is required for ciliary assembly and signaling	EMBO Reports	Rossella Delle Donne, Laura Rinaldi et al.	10
6	Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients	Pharmaceuticals	Francesca Alessandra Ambrosio, Antonio Lupia et al.	2
7	Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition	International Journal of Molecular Sciences	Antonio Lupia, Alessandro Deplano et al.	4
8	Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders	Chemical Communications	Federica Moraca, Francesco D’Amico et al.	13
9	GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation	Cells	Michele Biagioli, Silvia Marchianò et al.	16
10	Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma	Cells	Cristina Di Giorgio, Antonio Lupia et al.	9
11	Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease	Frontiers in Pharmacology	Stefano Fiorucci, Rosalinda Roselli et al.	6
12	Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents	Journal of Enzyme Inhibition and Medicinal Chemistry	Alessandro Deplano, Jessica Karlsson et al.	5
13	Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen	Journal of Enzyme Inhibition and Medicinal Chemistry	Alessandro Deplano, Jessica Karlsson et al.	14
14	Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors	Journal of Enzyme Inhibition and Medicinal Chemistry	Alessandro Deplano, Mariateresa Cipriano et al.	11
15	Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives	European Journal of Medicinal Chemistry	Raffaella Catalano, Federica Moraca et al.	19
16	Novel propanamides as fatty acid amide hydrolase inhibitors	European Journal of Medicinal Chemistry	Alessandro Deplano, Monica Demurtas et al.	10
17	Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode	PLoS ONE	Jessica Karlsson, Alessandro Deplano et al.	12
18	Development of Potent and Selective Peripheral 5-HT3 Receptor Agonists and Antagonists, Keystones of a New Therapeutic Strategy to Cardiac Diseases	Fundamental and Clinical Pharmacology	Roberta Budriesi, Pierfranco Ioan et al.	1
19	Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors: Past, Present, and Future Perspectives	Current Pharmaceutical Design	Giuseppe Campiani, Anna Ramunno et al.	101
20	SYNTHETIC POLYNUCLEOTIDES AND ANALOGUES AS MODELS FOR STUDIES CONCERNING DNA	Gazzetta chimica italiana	Bruno Catalanotti, Aldo Galeone et al.	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact